Evidence map›Paper›PMID 32779449›Full record

ReviewCell journal2020

Induced Pluripotent Stem Cell Meets Severe Combined Immunodeficiency.

Reza Kouchaki, Bahareh Abd-Nikfarjam, Amir Hosein Maali, Saeid Abroun, Farshad Foroughi, Sasan Ghaffari, Mehdi Azad

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cell journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Reza KouchakiFaculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Bahareh Abd-NikfarjamDepartment of Immunology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Amir Hosein MaaliStudent Research Committee, Pasteur Institute of Iran, Tehran, Iran.
Saeid AbrounDepartment of Hematology and Blood Banking, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Farshad ForoughiDepartment of Immunology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Sasan GhaffariHematology Department, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mehdi AzadFaculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran. Electronic Address: haematologicca@gmail.com.
Qazvin University of Medical Sciences · IRPasteur Institute of Iran · IRTarbiat Modares University · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe combined immunodeficiency (SCID) is classified as a primary immunodeficiency, which is characterized by impaired T-lymphocytes differentiation.

Indexed as

Hematopoietic Stem Cell TransplantationInduced Pluripotent Stem CellPrimary ImmunodeficiencySevere Combined Immunodeficiency

Identifiers

PMID32779449
PMCPMC7481889
OpenAlexW3048520768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.